Introduction
scale validity assess internal construct validity (the extent to which PRO instrument item scores are related statistically or 'internally consistent' 8 ) , and external construct validity (the extent to which the PRO instrument's scores correlate as expected with relevant other measures, 9, 10 detect known group differences, 11 and support/refute hypotheses 8, 10 ).
After many PRO instruments have been developed, evaluation of their reliability, validity and responsiveness is ongoing. However, examinations of PRO instrument validity are rarely comprehensive and typically limited to statistical tests. 12 This might be because establishing content and face validity is considered the role of the development phase, and therefore taken for granted in post hoc validity studies. Another explanation is that the psychometric literature over-emphasises statistical testing and lacks guidance on the application and interpretation of qualitative evaluations. These observations provide the context for our study: a comprehensive, two-stage, qualitative and quantitative PRO instrument evaluation to examine the clinical implications of this potential imbalance. 4 We selected for evaluation the 40-item Fatigue Impact Scale, a widely used PRO instrument developed using standard methods (FIS; Tables 1 and 2 show the items 13 ). It has three subscales purporting to measure fatigue impact on physical (10 items), cognitive (10 items) and social (20 items) function. In addition to being used illustratively, our fatigue PRO instrument evaluation is an important end in itself because fatigue is a common, disabling, poorly understood symptom of many neurological disorders. It is the most common symptom in multiple sclerosis (MS): up to 95% report notable fatigue and 40% regard it their most disabling symptom. 14 Despite, therefore, a great need for rigorous fatigue measurement a review of over 30 fatigue scales concluded that the reliability, validity and responsiveness of most have been under-evaluated. 15 
Methods
We examined the FIS in two ways: 1) a qualitative evaluation of subscale item content and specificity to fatigue, based on consensus expert opinion; and 2) a quantitative evaluation of performance as a measurement instrument involving two types of psychometric analyses − traditional methods based on Classical Test Theory 16 and modern methods based on Rasch Measurement Theory. 17 An extended referenced account of the methods and results is reported as a supplementary file (see supplementary data online).
Phase 1: Qualitative evaluation of FIS content and face validity
Thirty MS health professionals and researchers were used to ascertain the 'clinical' validity of the FIS: the extent to which items reflected the specific impact of fatigue in relation to cognitive, physical and social functioning. We used a modified consensus development conference method. 18 Items were shown to the 30 individuals, independently, without titles, response categories or proposed subscale grouping. Each participant was asked to group the 40 items into clinically sensible domains, and name those domains. Responses were collated so that FIS items were grouped under common summarised theme headings reflecting the majority view. Each person was then asked the extent to which they agreed with the summary document. An iterative process continued until consensus was reached. Finally, we asked each person to categorise each item as either specific to fatigue, non-specific to fatigue or not related to fatigue.
Phase 2: Psychometric evaluation of FIS internal and external construct validity
We analysed questionnaire data from people with neurologist-confirmed MS participating in a longitudinal study. Participants completed the FIS and three other PRO instruments: Multiple Sclerosis Impact Scale (MSIS-29), MS Walking Scale (MSWS-12) and General Health Questionnaire (GHQ-30). First, we examined two prerequisites for adequate psychometric evaluation: data availability (percentage missing item responses) and scale-to-sample targeting (score means, standard deviations and floor/ceiling effects). Next, and to ensure our findings were not single-method dependent, the data were analysed using two different but complementary psychometric evaluation approaches, traditional methods and the modern Rasch Measurement Theory.
Traditional psychometric analyses predominantly use correlations or descriptive statistics to evaluate scaling assumptions (legitimacy of summing items), score reliability and validity. 4, 19 We examined FIS data against published criteria for scaling assumptions (similarity of item means and variances, magnitude and similarity of corrected itemtotal correlations), and internal consistency reliability (Cronbach's alpha, homogeneity coefficients). Four types of analyses provided evidence towards establishing validity: inter-subscale correlations (correlations between FIS subscales); item convergent and discriminant construct validity (correlations between FIS item and FIS subscale scores); principal components analyses; and convergent and discriminant construct validity (correlations with other scales).
We examined correlations between FIS subscale scores and scores on other instruments appearing to measure related and unrelated constructs, and which were completed concurrently (MS Impact Scale (MSIS-29], MS Walking Scale (MSWS-12) and the 30-item version of the General Health Questionnaire (GHQ-30). We examined the extent to which the direction, magnitude and pattern of correlations between scales were consistent with our expectations based on the proximity of the constructs they measured. The specific hypotheses tested are detailed in the supplementary data file.
Rasch Measurement Theory analyses use a mathematical model as the criterion for testing PRO instrument performance. Comprehensive accounts are reported elsewhere. 20, 21 Specifically, we examined the extent to which items in each FIS subscale: had response categories that worked as intended (threshold ordering; threshold probability curves); formed a statistically cohesive group (fit residuals; chi square statistics; item characteristic curves); did not bias responses to each other (residual correlations); and separated individuals in the sample reliably (person separation index). Other Rasch measurement analyses with counterparts in traditional psychometric methods (e.g. correlating Rasch-derived measurements from different scales) are not reported because the substantive conclusions are essentially the same as using the traditional analysis. All correlations reported are Pearson product moment correlation coefficients. The reasons underpinning this choice are explained in the supplementary online file. Data availability and scale-to-sample targeting (Tables 2 and  3 ). Data were robust for the purpose of psychometric evaluations. Item-level missing data were low (≤4.5%) and all three scales were targeted sufficiently well to the sample.
Traditional psychometric analyses Reliability ( Table 3 ). All three FIS subscales satisfied most published criteria for scaling assumptions and reliability. This implied FIS subscales had: statistically conformable items; that summing item scores to generate subscale scores for individuals was legitimate; and that subscale scores were reliable measures.
Validity. Two FIS inter-subscale correlations (social with cognitive=0.81; social with physical=0.82) were higher than expected conceptually, implying measurement overlap between these subscale pairs.
Item-convergent and discriminant validity (correlations in Table 4 ; scaling success rates in Table 3 ) generally supported the distinctiveness of the cognitive and physical subscales relative to each other. Nevertheless, four items (40%) in each of these two subscales had high, or higher, correlations with other subscales implying notable overlap among subscales. There was less support for the social subscale's distinctiveness: 17/20 items (85%) had similar associations with two or more subscales and were therefore non-specific for any one subscale.
Principal component analyses supported the cognitive and physical subscales as distinct item groups. The 20 social subscale items were not identified as a cohesive group distinct from the groups purporting to measure cognitive and physical functioning ( Table 3) .
Correlations between scales (Table 3) provided some support for FIS subscale validity: the FIS physical subscale correlated higher with the MSIS-29 physical impact subscale (0.76) and MSWS-12 (0.69) than with the two unrelated measures of psychological functioning (0.60, 0.45); the FIS cognitive subscale correlated higher with the MSIS-29 psychological impact subscale scale (0.71) and GHQ-30 (0.55) than with unrelated measures of physical functioning (0.34, 0.53); the FIS social subscale showed similar correlations with all four other measures (0.52−0.73), although slightly over the 0.70 criterion for the MSIS-29 scales. Table 5 ). Results generally supported the summing of items within each subscale to form a total score. First, patients' responses to FIS items were largely consistent with Rasch measurement model expectations. Most items in each subscale had fit residuals in the recommended range (−2.5 to +2.5), and non-significant chi-square values. A graphical examination implied that only three items (one physical, two social) showed weak fit. These findings imply that FIS subscale items formed statistically conformable sets in which the responses of a person to the items in each subscale can be summed to generate scores. Second, most residual correlations (273/280) were <0.30, implying no inter-dependency (scoring bias) among items. Third, subscale reliability was supported by high Person Separation Indices (>0.92).
Rasch Measurement Theory analyses (
Whilst these conclusions are consistent with those from the traditional psychometric analysis, Rasch measurement analyses provided additional information regarding the relative intensity of items on the purported 'fatigue' continua. The item locations in each subscale were reasonably well spread out (social −0.70 to +0.88; cognitive −0.82 to +1.01; physical −0.97 to +1.54), implying that each FIS subscale had the potential to define a valid continuum. Also, Rasch analyses provided critical evidence regarding the empirical operation of the successive response categories. Correct empirical ordering of the response category thresholds was evident for 38 of 40 items.
Discussion
High stakes health care decisions are increasingly based on PRO instrument data. 4 However, examinations of the extent to which PRO instruments measure the substantive variables they purport to measure, their validity, are typically limited to statistically based psychometric evaluations which our study demonstrates do not address substantive validity. Here, both statistical approaches (traditional and Rasch measurement) implied, by and large, that all three FIS subscales were valid psychometrically. However, our clinical panel considered all 40 FIS items to be non-specific to fatigue, and therefore, if it purported to assess the impact of fatigue, to not be valid substantively.
Why did the validity examination 'pass' statistical but 'fail' clinical scrutiny? Our explanation has three parts. First, the two assessments address different questions therefore different conclusions are possible. Second, standard psychometric statistical tests of validity do not provide direct or confirmatory evidence of what is being measured. The extent to which a set of items is cohesive (tests of internal construct validity) may indicate that something is being measured but does not inform what it is. Similarly, correlations between PRO instrument scores (regardless of the validity of the validating instruments), detecting differences (10, 9, 20, 22, 25, 27) formed a statistically cohesive set with these 10 items. .73 (0.62-0.84) a When items of a scale are correctly grouped into subscales each item should correlate significantly higher with the total score of the scale in which it is purported to belong (item-own scale correlation with 95% confidence intervals in parentheses, bolded), than with the total scores of the other scale in which it is not purported to belong (item other-scale correlations). When this is the case a definite scaling suc cess is scored.
When an item-own scale correlation exceeds an item-other scale correlation, but not significantly -i.e. the item-other scale correlation equals or exceeds the lower limit 95% CI of the item-own scale correlation -a probable scaling success is scored (relevant item other-scale correlations in bold italic). When an item-own scale correlation is equalled or exceeded by an item-other scale correlation, but not significantly (i.e. less than upper limit 95%CI), a probable scaling failure is scored (relevant item-other scale correlations in bold italic with single asterisk). When an item-own scale correlation is significantly exceeded by an item-other scale correlation (i.e. above its upper limit 95% CI) a definite scaling failure is scored (relevant item-other scale correlations in bold italic with 2 asterisks). b In parentheses are the lower and upper limit 95% confidence intervals for the item-own scale correlations, computed as: correlation coefficient −/+ [1.96 × 1/√n]= value -/+ 0.11. between groups, and supporting/refuting hypotheses about constructs (tests of external construct validity) are conceptually poor tests of validity providing, at best, weak circumstantial evidence. 22 Third, all 40 FIS items are non-specific indicators of functioning. As such, responses to them will be correlated (the basis of traditional psychometric analyses) and related probabilistically (the basis of Rasch Measurement Theory analyses). Thus statistical tests of PRO instrument validity can mislead when they fail to target the intended substantive variable. How did this concerning situation arise given the FIS was developed using standard methods of item selection (identification from existing scales) and item generation (from patient interviews)? The main explanation is that standard methods neither advocate strongly, nor enable, explicit understandings of the substantive variable for measurement. The reasons for this appear historic. The measurement scale literature has placed greater emphasis on statistical than on qualitative aspects of scale development and evaluation. Not surprisingly, the guidance is not well developed for defining and conceptualising complex variables like fatigue, and subsequently representing them through sets of items. Our results question severely the adequacy of taking for granted the substantive validity achieved using standard processes. This raises further questions about using correlations between scales as a validation process.
These findings have substantial clinical and research implications. Clinically, it means that responses to all FIS items are confounded by multiple factors related to functioning in a broad sense, of which fatigue is just one. Consequently, FIS scores (and modified FIS scores derivable from them 23 ) cannot be interpreted confidently as valid indicators of fatigue impact. This may explain why some fatigue treatments have been found ineffective in quantitative-based, 24 but not qualitative-based 25 studies and in clinical practice. The implication for rating scale research is clear: we need to ensure that PRO instruments are both psychometrically robust and substantively valid.
One recommendation from our findings is that PRO instrument validity evaluations should include qualitative assessments of clinical validity, unless previously confirmed. So, what method? We used clinical opinion to help understand the FIS domains, item groupings and item specificity to fatigue impact. Had consensus supported the FIS, further stages would have been needed to test how well items in each subscale map out a clinically meaningful variable. This is required because PRO instruments are indirect measurement methods. In this instance, fatigue cannot be measured directly and is measured instead through scores which must accurately rate the intensity of its manifestations. 4 This requires clearly defined, targeted and conceptualised questions.
Three complementary techniques drawn from this paper could help here. First, experts in a field could be asked to assess the relevance of the items to a construct using the techniques described in this paper. Second, experts could be asked to compare items in pairs in terms of their relative intensity in reflecting the impact of fatigue (including a design where all experts do not need to assess all pairs but only overlapping pairs). An analysis of these paired comparisons, consistent with a Rasch Measurement Theory analysis, can be conducted. Third, relevant persons with MS could be asked to respond to the final questions and their responses checked against the experts' ordering of items. 26 These two techniques contribute validity evidence because they test hypothesised item ordering consistent with Rasch Measurement Theory.
A second recommendation arising from our study is that new PRO instrument development should be underpinned by a strong conceptual base from the outset. Items must target precisely what is being measured with a clear qualitative understanding, which can be confirmed or refuted using hypothesis testing approaches. Unfortunately, strong, theoretically driven approaches seem to be rare and most PRO instruments are developed primarily empirically. Typically a pool of seemingly relevant items is generated and grouped into subscales on the basis of statistical tests or thematic similarity. This common approach has two potential limitations: grouping items statistically does not ensure that they measure the same substantive variable; and grouping items thematically does not ensure they map out a variable in a clinically meaningful fashion. Moreover, taking this very post hoc empirical and statistical approach may mean that PRO instrument developers might not invest fully in the process of defining, conceptualising and operationalising variables that is central to valid and interpretable measurement. The fact that psychometric evaluations can imply robust measurement in the face of weak clinical validity simply serves to emphasise this need further.
Encouragingly, the US Food and Drug Administration's (FDA) scientific requirements for PRO instruments in clinical trials 1 highlights the importance of establishing clinical meaningful 'content' validity and interpretable measurement. However, the FDA's document provides little detailed guidance on how these can be achieved, largely because the field is poorly developed. Recently, this has sparked developments. 27, 28 We suggest greater use of qualitative assessments is vital and should include evaluating the extent to which a scale's items map out the construct to be measured, establishing the most appropriate item phrasing, structuring and context. In particular, we advocate the development of explicit theories of the constructs being measured, and explicit methods of testing those theories. 22 An example is described elsewhere. 4 Our findings must not be misinterpreted as implying psychometric statistical tests have limited value. They are an essential part of PRO instrument development and evaluation providing necessary, but not sufficient, information. However, their usefulness is maximised when PRO instrument items are generated from strong conceptual bases.
When this is the case psychometric statistics can become an hypothesis test for the PRO instrument as a measurement instrument. Eventually, when PRO instrument development advances to being theory-referenced, a level sometimes achieved, 22 statistics in the form of construct specification equations become the confirmatory tests of validity.
One Reviewer of this article asked: should the 40 FIS items be considered a global MS health measure as they capture many health effects of MS, while not necessarily attributing them to fatigue? We agree the items relate to many important health effects of MS, and there is an argument that the demonstration of adequate psychometric properties indicates that something is being measured. However, we believe it would be premature to consider the items as a global MS measure until there is clarity concerning exactly what is meant by global MS health, a construct definition and clear conceptualisation against which the items can be mapped to determine their validity. Measuring important and complex health constructs is very challenging. Without strong conceptual foundations the MS community is left very uncertain as to what is being measured, if anything.
To our knowledge no existing fatigue PRO instrument has a strong conceptual basis for measurement. Indeed, the ability to define fatigue, particularly in a way that differentiates it from everyday tiredness and sleepiness, or from the more general symptoms and impairments associated with a disease such as MS, is acknowledged to be the greatest challenge to fatigue measurement. 15 The fact that it has not yet been achieved explains, in part, why there are more than 30 fatigue PRO instruments, 15 and the limited progress made in understanding and treating this very common disabling symptom. 29 The issues highlighted by this study seem not to be unique to fatigue measurement, nor the FIS. In health outcomes measurement, strong conceptual underpinnings are not as common as would be desirable. 30 The potential consequences, in terms of PRO instruments misguiding patient care and misleading research, seem to be under-appreciated at a time when PRO instruments have been recommended for routine use as outcome measures in clinical trials 1 and UK clinical practice. 3 We believe the case is strong for a paradigm shift from what might be seen as a strong psychometric, empiricist approach for selecting items from a large pool of potential items which have been generated using a relatively weak theoretical basis, to one in which a smaller number of potential items using a much stronger theoretical foundation ensuring validity are generated, and where a majority of items can be shown to conform to strong measurement theory.
